A history of sickle cell disease and pharmaceuticals SCD gained ... which is now known as global biotechnology leader CSL Behring; US plasma collector Nabi, which helped to form the world ...

adding that further understanding of the long-lived plasma cell subset—known to be resistant to immunosuppressive therapy—might improve treatment of this disease. Pathology in pSS manifests ...

Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, with disease progression ranging from slow and indolent to ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

You will not need treatment for MGUS as long as the level of m-protein does not rise. Your MSK care team can guide your local healthcare provider as they monitor MGUS. They will watch to see if MGUS ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Plasma Cell Disorders Working Committee, Center for International Blood & Marrow Transplant Research (CIBMTR) Member, Plasma Cell Disorders Working Committee Center for International Blood & Marrow ...